stocktive logo
United States ▻ Healthcare
IDEXX Laboratories
Tea Leaves Summary
IDEXX Laboratories [NASDAQ:IDXX] share price
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Quick Section Links
→ Sentiment
sentiment score
→ Positions
positions score
→ Growth
growth score
→ Value
value score
→ Health
health score
→ Earth
earth score
Page Updated: Aug 20, 2019

IDEXX Laboratories [NASDAQ:IDXX] share price, stock quote Analysis

What has the stock performance of IDEXX Laboratories been like?
stock quote price chart

IDEXX Laboratories's (NASDAQ:IDXX) stock is 16.8% higher in the past 12 months and has outperformed the overall US TECH market which is 3.1% higher in the same timeframe. This equates to a 13.7% greater return over the period which puts the stock as an outperformer vs other US TECH companies.


Tea Leaves Score
sentiment tea score

Analyst RatingS

What are analyst ratings for IDEXX Laboratories?
Analyst Ratings
Analyst Ratings Change
analyst ratings

From 10 analysts that cover IDEXX Laboratories's stock, the average rating is 3.9. This is a weighted average of 4 strong buys, 2 buys, 3 holds, 1 sells. This is 0.5 lower than a month ago which gives this factor a tea-score of 1/5.


Tea Leaves Score
positions tea score

Insider Trades

What has IDEXX Laboratories's insider trading been over the past year?
insider trading chart

IDEXX Laboratories insider's have net been buying stock over the past 12 months, in the previous month insiders have been net buying. In fact the buy to sell ratio in the past month has been 50.0% which is 49.0% higher than the last 12 months buy to sell ratio. This put's IDEXX Laboratories's Insiders in the top quintile vs their peers giving this factor a tea-score of 1/5.


What is the ownership of IDEXX Laboratories stock?
ownership chart

For IDEXX Laboratories, currently 90.9% of stock (1 billion shares) is owned by Institutions, 7.5% (802 million shares) is owned by Individuals, and 1.6% (2 million shares) is owned by company insiders. The CEO has a holding of 0.02% which is equivalent to 40 thousand shares with a market value of $129 million. This factor has a tea-score of 3/5.

Short Interest

What is the short interest for IDEXX Laboratories stock?
short interest chart

As of 31 July 2019, the short interest for IDEXX Laboratories has been 1.44% of the shares outstanding which is 12 billion shares. This is more than 1 month ago which had 1.30% of the shares outstanding which is 11 billion short interest in shares. This equals a tea-score of 4/5.


Tea Leaves Score
growth tea leaves

Revenue & Earnings

What has IDEXX Laboratories's revenue history been by year?
revenue chart

IDEXX Laboratories's revenue in the last 12 months ending 30 June 2019 is $2Bn. IDEXX Laboratories's average revenue growth for the last 4 years has been 5.1% which is currently lower than their comps of 6.2%.

Free Cash Flow Yield Growth

What is IDEXX Laboratories's free cash flow yield?
free cash flow yield chart

IDEXX Laboratories's free cash flow yield is 1.8% and has grown from 4 years ago. The free cash flow yield for IDEXX Laboratories 1 year ago was 2.2% and 3 years ago it was 2.2%.

Dividend History & yield

What has IDEXX Laboratories's dividend payments been historically?
Dividend ($)
Dividend Yield (%)
dividend chart

IDEXX Laboratories hasn't paid any dividends for the past 4 years.


Tea Leaves Score
value tea leaves

PE Ratio

What is IDEXX Laboratories's PE ratio?
pe ratio

IDEXX Laboratories's PE ratio is 59.4x. This is calculated from their EPS of $2.02 and price per share of $275.41. IDEXX Laboratories's PE ratio values the company cheaper than 80% of it's competitors giving this factor a tea-score of 4/5.

PEG Ratio

What is IDEXX Laboratories's PEG ratio?
peg ratio

IDEXX Laboratories's PEG ratio is 3.8x. This is calculated from their PE ratio of 59.4x and their last 12 months growth rate of 0.157%. This is more attractive than their competitors so the tea-score for this factor is 5/5.

Share Price / Book (PB Ratio)

What is IDEXX Laboratories's PB ratio?
PB ratio

The PB ratio for IDEXX Laboratories is 138.5x. This is cheaper than their competitors who have an average PB ratio of 8.1x. The tea-score is 5/5.

Free Cash Flow Yield

What is IDEXX Laboratories's free cash flow yield?
free cash flow yield

IDEXX Laboratories's free cash flow yield is 1.8% which is ranked 4.0/5 when compared to its competitors. This is calculated from a free cash flow of $372M (as reported for the 12 months ending 30 June 2019) divided by its current market capitalisation of $23Bn. The average free cash flow yield across IDEXX Laboratories's comps is 8.1%.

Return On Investment (ROI)

What is IDEXX Laboratories's return on investment (ROI)?
return on investment

IDEXX Laboratories's return on investment is 623.3%. This is less profitable than its competitors.


Tea Leaves Score
health tea leaves

Assets vs Liabilities

What is IDEXX Laboratories's current ratio (assets vs liabilities)?
assets vs liabilities

IDEXX Laboratories's current ratio is calculated by (current assets) / (current liabilities) which equals 1.2x. This less attractive than their competitors and also worse than recommended for a healthy company.

Debt vs Equity

What is IDEXX Laboratories's debt vs shareholder equity?
debt vs equity

IDEXX Laboratories's debt to shareholder equity is 604.1%. This is worse than their competitors and also worse than advised for a well-managed balance sheet.

Dividend Payout Ratio

What is IDEXX Laboratories's dividend payout ratio?
dividend payout ratio



Tea Leaves Score
ESG score
What is the overall ESG (environmental, social and corporate governance) rating for IDEXX Laboratories?

IDEXX Laboratories's has a poor overall ESG rating of 51/100. Their competitors have a score between 41 and 81 with the average at 59.

ESG Environmental

What the latest (ESG) environmental responsibility score for IDEXX Laboratories vs their competitors?
ESG environmental
We can see here what the environmental consciousness of IDEXX Laboratories is relative to other similar companies.

ESG Social

What the present (ESG) social responsibility score for IDEXX Laboratories vs their peers?
ESG social
We can get a sense of what the social responsbility of IDEXX Laboratories is when compared to other rival companies.

ESG Corporate Governance

What the current (ESG) corporate governance score for IDEXX Laboratories vs their challengers?
ESG corporate governance
With this number we can understand what the corporate governance of IDEXX Laboratories is when compared to it's peers.



What is the company description of IDEXX Laboratories?
IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments.

IDEXX Laboratories [NASDAQ:IDXX] Additional Q&A

Questions & Answers

What is the 52 week high for IDEXX Laboratories stock quote?

IDEXX Laboratories (NASDAQ:IDXX) hit a new 52-week high on 18 July 2019 at a price of $289.85 with 360,700 shares traded that day. This is 5.2% higher than than its current price of $275.41 and 64.5% higher than the 52-week low of $176.18 on 24 December 2018. Average daily volume traded has been 378 thousand shares over the past 3 months.

What is the highest price IDEXX Laboratories stock has ever been?

The all-time highs for IDEXX Laboratories stock were reached on 18 July 2019, 32 days ago at a price of $289.85. This equates to a market capitalisation of $24Bn. The highest price reached is 5.2% higher than the current price of $275.41 with a current market cap of $23Bn.

What is the beta of IDEXX Laboratories stock?

IDEXX Laboratories stock moves 1.2x the US TECH market average which makes its beta higher than the overall market.

What is the volatility of IDEXX Laboratories (IDXX) stock?

IDEXX Laboratories's stock has an annual volatility of 28.5% which is more volatile than the average US TECH market volatility of 20.8% which has made it a less safe stock to own in the past vs just owning the index for investors aiming for lower portfolio volatility.

What have IDEXX Laboratories's share buybacks been over the past year?

IDEXX Laboratories is currently running a share-buyback program and in the past year alone the company has repurchased 104 million of shares outstanding at a total expense of $23Trn. In the same time frame the share price has moved 16.8% higher which is an outperformance of 13.7% vs the overall market. IDEXX Laboratories still has $420Trn of cash remaining on their balance sheet.

Who owns the most IDEXX Laboratories stock?

Barry White is the largest individual shareholder in IDEXX Laboratories with 1 billion shares. He is an independent director of IDEXX Laboratories. The largest institutional holder is T-Rowe and they own 116.2% of the issue size with 100 million shares. T-Rowe have been net buying shares over the last 12 months as they own 1 million more shares than a year ago.

When did IDEXX Laboratories beat earnings expectations in the last 4 years?

In the past 4 quarters IDEXX Laboratories has had 3 earnings beat's and 1 earnings miss's. The average earnings beat has been 12.1% and the average earnings miss has been 8.2%.

When is IDEXX Laboratories's next earnings date and what are the expectations?

IDEXX Laboratories is set to report earnings on 30 July 2019 after market close. The report will be for the fiscal Quarter ending June 2019. Based on 14 analysts' forecasts, the consensus EPS forecast for the quarter is $2.12. Recent analyst revisions have been positive implying a potential EPS of $2.24.

What is IDEXX Laboratories's upcoming earnings report expectations?

The earnings expectations for IDEXX Laboratories's upcoming report on 30 July 2019 are from 14 analysts with an average EPS of $2.12. The lowest analyst rating is $2.01, the highest is $2.84. The most recent earnings revisions have been positive with a most recent estimate of $2.24.

What is IDEXX Laboratories's earnings per share (EPS)?

IDEXX Laboratories's latest earnings per share (EPS) was reported as $2.02 on 30 April 2019 for fiscal quarter ending March 2019. This is 11.0% higher than 12 months ago when they reported EPS of $1.82

What is IDEXX Laboratories's dividend growth rate?


What is IDEXX Laboratories's dividend yield?


What is IDEXX Laboratories's previous and next dividend date?


By using this website, you accept our Terms of Use and Privacy Policy. Stocktive is not a registered investment advisory service and the information presented on this site is not intended for investment purposes. You can find out more about the team that built Stocktive on our team page. If you'd like investment advisory services we have an investment partner. Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities. Past performance is no guarantee of future results. Any historical returns, expected returns or probability projections are hypothetical in nature and may not reflect actual future performance. The analysis presented herein, the stock price, and anything related are for illustrative purposes only and are not investment recommendations. If you'd like further information about fundamental analysis you can check out a detailed wiki page.
© 2019 StockForecast
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.